Octavian Bucur
Octavian Bucur (born December 21, 1980) is a Romanian-American scientist and the General Director of the Genomics Research and Development Institute (GRDI) in Bucharest, Romania.[1][2]. Internationally recognized for his pioneering contributions in cancer research and diagnostic pathology[1][2][3], Dr. Bucur is playing a key role in advancing genomic research and genomic infrastructure in Romania and Eastern Europe. He also serves as an Associate Investigator at the Viron Molecular Medicine Institute in Boston, USA[3] and is a Romanian Representative to the 1+ Million Genomes European initiative (1+MG)[2]
Early Life and Education
Dr. Bucur was born in Craiova, Romania in the Oltenia region. He showed early on interest in mathematics and physics, participating in numerous competitions in Middle and High School, including Romanian National Olympiad of Physics in 11th grade and National Olympiad of Biology in 12th grade. Due to his outstanding results, in particular the prize obtained at the National Biology Olympiad (Genetics).[4], he earned a scholarship to attend the university of his choice in Romania[5]. In 1999, Bucur enrolled in the Carol Davila University of Medicine and Pharmacy in Bucharest. As a medical student, he worked with Dr. Mircea Leabu and Roxana Nat, publishing his first author original manuscript early on during his Medical School[6].
Immediately after obtaining his MD in 2005, Bucur started his research fellow position at the Harvard University and completed his PhD in Biology/Biochemistry offered by the Romanian Academy/Institute of Biochemistry, where he graduated with the highest distinction. His doctoral training and research were conducted at the Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, under supervision of Prof. Roya Khosravi-Far and Prof. Alex Almasan. He then trained as a postdoc at Harvard Medical School with Prof. Andrew H. Beck, focused on molecular, digital, and computational pathology, with a specific focus on biomedical technology development and artificial intelligence (AI) applications in Pathology. He also obtained a Certificate in Applied Biostatistics from the Harvard Clinical and Translational Science Center in 2017[2][3][4][5][6][7]. He has over a decade of training and research at Harvard Medical School: Postdoctoral Fellow at BIDMC and Harvard Medical School, Instructor in Pathology, Harvard Medical School (2017-2018); Associate Member, Wyss Institute of Biologically Inspired Engineering at Harvard, in Prof. George Church's laboratory (2014-2015), Associate Member of the Ludwig Cancer Center at Harvard University, Boston, MA (2016-2018), affiliated with Broad Institute of MIT and Harvard on Genomics, Boston, MA (2016-2018)[2][3].
Dr. Octavian Bucur is a Romanian Representative to the European +1 Million Genomes Initiative (2023 - present; nominated by the Romanian Ministry of Research, Innovation and Digitalization) and the Honorary Scientific Advisor of the Carol Davila University of Medicine and Pharmacy’s Rector (2023 - present), becoming the General Director of the Genomics Research and Developing Institute in October 2023[1][2].
Dr. Bucur’s scientific career spans leading roles in academia, research institutions, and biotech startups. He co-founded Viron Therapeutics LLC (now Porosome Therapeutics)[8] in Boston, MA, USA and served as CEO, helping to translate laboratory discoveries into commercial ventures. He is also Co-Founder and Editor-in-Chief of Discoveries, a peer-reviewed PubMed indexed journal[9].
Research
Bucur and his collaborators from Harvard and MIT (Drs. Yongxin Zhao, Dr. Edward Boyden, Dr. Andrew Beck) have pioneered methods in several research fields being one of the main developers of Expansion Pathology (Nature Biotechnology 2017 shared first author (in the top 5% of all research outputs scored by Altmetric), Nature Protocols 2020; several patents)[6,7,8,9,10]. Instead of creating better microscopes, the approach involves physically expanding the fixed tissues about 100x in volume (4-5 times in each dimension). This method extends the current resolution limit (250 nm) of the optical microscopes to 70 nm, enabling visualization of smaller nanoscopic structures with inexpensive optical microscopy in preserved tissue specimens, after physical tissue expansion. Expansion-related technologies have tremendous implications in several biomedical fields, including diagnostic pathology, spatial genomics, neuroscience and molecular medicine[10][11][12][13][14][15][16].
Dr. Octavian Bucur was a collaborator in Prof. George Church laboratory at the Wyss Institute at Harvard, working on the development of the Fluorescence in Situ Sequencing (FISSEQ) spatial genomics technology, which has impactful applications in genomics, genetics and other medical fields[2][3].
In 2023, he was appointed Romanian Representative to the European 1+ Million Genomes initiative and the European Infrastructure for Drug Repurposing (RePo4EU). As the General Director of GRDI, within the first year, the institute become a partner and beneficiary in the most important European Projects on Genomics, such as the Genomic Data Infrastructure (GDI), Genome of Europe and Beyond 1 Million Genomes Plus (B1MGPlus)[2][3][6]. In addition, Bucur secured through the ROGEN project nearly €19 million in funding within 10 months to develop the institute, advance sequencing, genomics and computational genomics research infrastructure in Romania and develop, together with ROGEN partners, the Romanian Reference Genome within the next 5 years. This projects started in December 2024[17][18].
Honors and Awards
Dr. Bucur has received numerous prestigious honors for his research contributions and leadership in biomedical science[2][3], including:
- Recognition of Outstanding Achievement in Translational and Basic Science Research, Harvard Medical School Pathology Department (2017);
- Beth Israel Deaconess Medical Center's 10 Years of Pathology Dedicated Research Award (2017).
- Finalist, Harvard Medical PD Elevator Pitch Competition (2018), Boston, MA.
- American Association for Cancer Research (AACR)-Millennium Pharmaceuticals Award (2015)
- Lady Tata Memorial Trust International Award for Leukemia Research (2007-2008)
- AACR-Aflac Award, American Association for Cancer Research (2008)
- European Union Leonardo da Vinci Research Fellowship Award (2004)
- IUBMB Travel Fellowship (2010), Melbourne, Australia
- Romanian Government Research Fellowship Award (2003-2004)
In Romania he received the Top Romanian Young Scientist Award (2023) during a Romanian Research Gala[19][20], distinction offered by the Romanian Ministry of Research, Innovation, and Digitalization. He also received the Carol Davila Award for Accomplishment in Medicine (2023), awarded by MLNR and the Romanian Academy[21][22]
References
- ↑ 1.0 1.1 1.2 "Genomics Research and Development Institute - Directors".[permanent dead link]
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 "Dr. Octavian Bucur - Genomics Research and Development Institute".[permanent dead link]
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 "Octavian Bucur - Viron Molecular Medicine Institute".
- ↑ 4.0 4.1 "Beyond Black and White with Dr. Octavian Bucur (@TVR1)".[permanent dead link]
- ↑ 5.0 5.1 "Interview on the TV show "A second Romania" with Dr. Octavian Bucur (@TVRi)".[permanent dead link]
- ↑ 6.0 6.1 6.2 "Interview on the TV show "A doctor for you - the return that heals"".
- ↑ "Radio Romania interview on medical genomics".
- ↑ "Porosome Therapeutics former "Viron Therapeutics"".
- ↑ "Discoveries journal".
- ↑ Zhao, Y.; Bucur, O.; Irshad, H.; Chen, F.; Weins, A.; Stancu, A. L.; Oh, E. Y.; Distasio, M.; Torous, V.; Glass, B.; Stillman, I. E.; Schnitt, S. J.; Beck, A. H.; Boyden, E. S. (2017). "Zhao Y, Bucur O, Irshad H, Chen F, Weins A, Stancu AL, Oh EY, DiStasio M, Torous V, Glass B, Stillman IE, Schnitt SJ, Beck AH, Boyden ES. Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy. Nat Biotechnol. 2017 Aug;35(8):757-764. doi: 10.1038/nbt.3892. Epub 2017 Jul 17. PMID: 28714966; PMCID: PMC5548617". Nature Biotechnology. 35 (8): 757–764. doi:10.1038/nbt.3892. PMC 5548617. PMID 28714966.
- ↑ Bucur, O.; Fu, F.; Calderon, M.; Mylvaganam, G. H.; Ly, N. L.; Day, J.; Watkin, S.; Walker, B. D.; Boyden, E. S.; Zhao, Y. (2020). "Bucur O, Fu F, Calderon M, Mylvaganam GH, Ly NL, Day J, Watkin S, Walker BD, Boyden ES, Zhao Y. Nanoscale imaging of clinical specimens using conventional and rapid-expansion pathology. Nat Protoc. 2020 May;15(5):1649-1672. doi: 10.1038/s41596-020-0300-1. Epub 2020 Apr 1. PMID: 32238952; PMCID: PMC7490752". Nature Protocols. 15 (5): 1649–1672. doi:10.1038/s41596-020-0300-1. PMC 7490752 Check
|pmc=value (help). PMID 32238952 Check|pmid=value (help). - ↑ "Patent "Methods for Diagnosing Neoplastic Lesions", WO US US20200041514A1; Inventos: Edward Stuart Boyden, Andrew Hanno Beck, Yongxin Zhao, Octavian Bucur, Humayun Irshad; Current Assignees: Beth Israel Deaconess Medical Center Inc Massachusetts Institute of Technology; Priority 2017-02-24 • Filed 2019-08-15 • Published 2020-02-06".
- ↑ "Patent "Methods for Expanding Clinical Tissue Specimens", WO EP US CN JP CA US20190064037A1; Inventos: Edward Stuart Boyden, Andrew Hanno Beck, Yongxin Zhao, Octavian Bucur; Current Assignees: Beth Israel Deaconess Medical Center Inc Massachusetts Institute of Technology,; Priority 2016-02-25 • Filed 2017-02-24 • Published 2019-02-28".
- ↑ "Patent "Methods for examining podocyte foot processes in human renal samples using conventional optical microscopy", WO US US11802872B2; Inventos: Edward Stuart Boyden, Andrew Hanno Beck, Yongxin Zhao, Octavian Bucur; Current Assignees: Beth Israel Deaconess Medical Center Inc Massachusetts Institute of Technology; Priority 2017-02-24 • Filed 2019-08-15 • Granted 2023-10-31 • Published 2023-10-31".
- ↑ Bucur, O.; Zhao, Y. (2018). "Bucur O, Zhao Y. Nanoscale Imaging of Kidney Glomeruli Using Expansion Pathology. Front Med (Lausanne). 2018 Nov 21;5:322. doi: 10.3389/fmed.2018.00322. PMID: 30519560; PMCID: PMC6259469". Frontiers in Medicine. 5: 322. doi:10.3389/fmed.2018.00322. PMC 6259469. PMID 30519560.
- ↑ Fortner, A.; Bucur, O. (2024). "Fortner A, Bucur O. Multiplexed spatial transcriptomics methods and the application of expansion microscopy. Front Cell Dev Biol. 2024 Jul 22;12:1378875. doi: 10.3389/fcell.2024.1378875. PMID: 39105173; PMCID: PMC11298486". Frontiers in Cell and Developmental Biology. 12. doi:10.3389/fcell.2024.1378875. PMC 11298486 Check
|pmc=value (help). PMID 39105173 Check|pmid=value (help). - ↑ "ROGEN Project".
- ↑ "ICDG proiecte".[permanent dead link]
- ↑ "Gala Cercetarii Românești - Dr. Octavian Bucur a primit premiul la secțiunea tineri cercetători".[permanent dead link]
- ↑ "Gala Cercetării Românești". YouTube. 5 April 2023.
- ↑ "Gala Premiilor Marii Loji Nationale si Academiei Romane - Dr. Octavian Bucur a primit premiul Carol Davila pentru Medicina".[permanent dead link]
- ↑ "Gala Premiilor Marii Loji Nationale si Academiei Romane". YouTube. 21 June 2023.
This article "Octavian Bucur" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Octavian Bucur. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
